Related Experiment Video

Updated: Aug 14, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Targeting ligand cleavage to inhibit the ErbB pathway in cancer

Bin-Bing S Zhou1

  • 1Drug Discovery Biology, Incyte Corporation, Wilmington, DE 19880, USA. bzhou@incyte.com

Annals of the New York Academy of Sciences
|December 31, 2005
PubMed

Insights

Researchers identified small molecule inhibitors targeting ADAM proteases, which are key activators in the ErbB signaling pathway. These inhibitors block the shedding and activation of ErbB ligands, offering new therapeutic strategies for cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Biology

Background:

  • ADAMs (a disintegrin and metalloproteases) are zinc-dependent metalloproteases involved in shedding membrane-bound proteins.
  • ADAMs function as sheddases for multiple ErbB ligands within ErbB signaling pathways.
  • The ErbB pathway is a validated therapeutic target in oncology.

Purpose of the Study:

  • To identify and develop novel therapeutic strategies targeting ADAM proteases in cancer.
  • To investigate the role of ADAM proteases as upstream activators of ErbB ligands.

Main Methods:

  • Identification of selective small molecule inhibitors targeting ADAM proteases.
  • Assessment of inhibitor efficacy in blocking the shedding and activation of ErbB ligands.

Main Results:

  • Selective small molecule inhibitors of ADAM proteases were successfully identified.
  • These inhibitors effectively block the shedding and activation of multiple ErbB ligands.

Conclusions:

  • ADAM proteases are crucial targets in the ErbB signaling pathway for cancer therapy.
  • Developed small molecule inhibitors show potential for clinical application in treating cancers driven by ErbB signaling.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...